Endothelin is a potent vasoconstrictor, whereas endothelium-derived relaxing factor (EDRF) is a potent vasodilator. Both are produced by the endothelium. Although they have been studied extensively in large vessels, little is known about their actions in renal microvessels. Using microdissected rabbit afferent arterioles, we studied the vascular response to synthetic endothelin and its interaction with EDRF and the effect of endothelin on renin release. Afferent arterioles were either microperfused in vitro at 60 mm Hg to measure luminal diameter or incubated without microperfusion to assess renin release. When added to the bath, 10~1 0 or 10"' M endothelin decreased the diameter by 32±8% (n=7, /><0.01) or 76±7% (p<0.0001), respectively. Pretreatment with jV-nitro L-arginine, which inhibits synthesis of EDRF, decreased basal diameter by 15±1% (/><0.001) and augmented endothelin-induced constriction; decrease in diameter with 10"'° M endothelin was 78±10% (n=4, p<0.01 versus nontreated). T he endothelium produces vasodilators, collectively called endothelium-derived relaxing factors (EDRFs), 1 as well as vasoconstrictors, one of which has recently been identified and named endothelin.2 Although both endothelin and EDRF have been studied extensively in large vessels, little is known about their actions on the glomerular afferent arterioles or about possible interactions between them.In addition to its potent vasoconstrictor action, endothelin has been demonstrated to decrease renin release from rat renal cortical slices, 3 isolated glomeruli, 4 and dispersed rat renal cortical cells. 5 Because endothelin causes the increase in intracellular calcium that is proposed to mediate both vasocon-